Skip to content

Clinical trials

Phase 3 Neurodegenerative Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 3 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20163
20182
20191
20202
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics3
TauRx Therapeutics Ltd2
Alector Inc.1
AstraZeneca1
Emalex Biosciences Inc.1
H. Lundbeck A/S1
Hoffmann-La Roche1
Medivation, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases15
Nervous System Diseases10
Brain Diseases9
Central Nervous System Diseases7
Alzheimer Disease5
Dementia5
Movement Disorders5
Parkinson Disease4
Parkinsonian Disorders4
Eye Diseases3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.